PMID

Data

Article Title

Organization

Synthesis, characterization and antitubercular activities of novel pyrrolyl hydrazones and their Cu-complexes.

S.E.T'S College Of Pharmacy

Piperazine derivatives: synthesis, inhibition of the Mycobacterium tuberculosis enoyl-acyl carrier protein reductase and SAR studies.

Pontif£Cia Universidade Cat£Lica Do Rio Grande Do Sul

Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.

Birla Institute Of Technology

Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system.

Astrazeneca

2-Phenylindole and Arylsulphonamide: Novel Scaffolds Bactericidal against Mycobacterium tuberculosis.

Astrazeneca

Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis.

Birla Institute Of Technology

Encoded library technology as a source of hits for the discovery and lead optimization of a potent and selective class of bactericidal direct inhibitors of Mycobacterium tuberculosis InhA.

Glaxosmithkline

Methyl-thiazoles: a novel mode of inhibition with the potential to develop novel inhibitors targeting InhA in Mycobacterium tuberculosis.

Astrazeneca India

Identification of novel antimycobacterial chemical agents through the in silico multi-conformational structure-based drug screening of a large-scale chemical library.

Kyushu Institute Of Technology

Chemical synthesis and biological evaluation of triazole derivatives as inhibitors of InhA and antituberculosis agents.

Cnrs

Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitors.

Stony Brook University

2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.

University Of London

Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening.

China Pharmaceutical University

Natural products, small molecules, and genetics in tuberculosis drug development.

National Institute Of Diabetes And Digestive And Kidney Diseases

Agonodepsides a and B: two new depsides from a filamentous fungus F7524.

Institute Of Molecular And Cell Biology

Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis.

University Of Minnesota

Muscarinic receptor subtypes.

National Institute For Medical Research